Menu Search
Equities

Nanalysis Scientific Corp

NSCI:CVE

Nanalysis Scientific Corp

Actions
  • Price (CAD)0.38
  • Today's Change0.005 / 1.33%
  • Shares traded2.87k
  • 1 Year change-11.63%
  • Beta0.7128
Data delayed at least 15 minutes, as of Nov 14 2024 20:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CADIncome statement in CADView more

Year on year Nanalysis Scientific Corp had net income fall 63.35% from a loss of 9.92m to a larger loss of 16.20m despite a 14.69% increase in revenues from 24.82m to 28.47m. An increase in the cost of goods sold as a percentage of sales from 55.12% to 86.05% was a component in the falling net income despite rising revenues.
Gross margin22.58%
Net profit margin-32.75%
Operating margin-20.40%
Return on assets-20.87%
Return on equity-46.06%
Return on investment-29.36%
More ▼

Cash flow in CADView more

In 2023, cash reserves at Nanalysis Scientific Corp fell by 2.77m. Cash Flow from Financing totalled 14.48m or 50.87% of revenues. In addition the company used 11.19m for operations while cash used for investing totalled 6.06m.
Cash flow per share-0.0818
Price/Cash flow per share--
Book value per share0.2137
Tangible book value per share0.027
More ▼

Balance sheet in CADView more

Nanalysis Scientific Corp has a Debt to Total Capital ratio of 41.77%, a lower figure than the previous year's 48.62%.
Current ratio1.42
Quick ratio1.03
Total debt/total equity0.7172
Total debt/total capital0.4177
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.